Search - tctmd.com

Displaying 21 - 40 of 49

Sort: Relevancy | Date

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

News Conference News TCT 2022

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

Todd Neale

September 21, 2022

Presentation TCT 2021

Case 2: Removing Ambiguity in NSTE-ACS Using Intravascular Imaging by OCT vs IVUS – Direct Comparison

Presenter: Natalia Pinilla-Echeverri

November 06, 2021

News Conference News TCT 2021

Magnetic Endoscopy Capsule Reveals GI Damage Surprises From Antiplatelets

Caitlin E. Cox

November 06, 2021

News Conference News TCT 2021

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

Caitlin E. Cox

November 04, 2021

Presentation TCT 2019

Acute Coronary Syndromes: Treatment of NSTE-ACS and STEMI

Presenter: Gregory Serrao

September 25, 2019

News Conference News TCT 2018

Statin Preloading Benefit More Pronounced in STEMI Patients: SECURE-PCI

Michael O'Riordan

October 05, 2018

Presentation TCT 2018

Acute Coronary Syndromes: Treatment of NSTE-ACS and STEMI

Presenter: David A. Cox, Henning Kelbæk, Michael C. C. Kim

September 21, 2018

Presentation TCT 2017

Acute Coronary Syndromes: Treatment of NSTE-ACS and STEMI

Presenter: Grzegorz L. Kaluza, Jose M. Wiley, Michael C. Kim

October 29, 2017

Presentation TCT 2016

Case Introduction: What Device(s) to Choose in a Patient With NSTE-ACS?

Presenter: George D. Dangas, Fabio Felice Tarantino, Massimo Fineschi

November 01, 2016

Presentation TCT 2016

Case Conclusion: How Did We Treat Our Patient?

Presenter: Roxana Mehran, Ferdinando Varbella, Alberto Menozzi

November 01, 2016

Presentation TCT 2016

Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS

Presenter: Roxana Mehran, Ferdinando Varbella, Dominick J. Angiolillo

November 01, 2016

Presentation TCT 2016

To Pretreat or Not to Pretreat? The DUBIUS Trial

Presenter: Roxana Mehran, Ferdinando Varbella, Giuseppe Tarantini

November 01, 2016

Presentation TCT 2016

Case Introduction: An Elderly Patient With NSTE-ACS

Presenter: Roxana Mehran, Ferdinando Varbella, Alberto Menozzi

November 01, 2016

News Conference News TCT 2016

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Yael L. Maxwell

October 31, 2016

Presentation TCT 2016

Unmet Needs and Data Gaps for Pharmacotherapy in Patients With NSTE-ACS

Presenter: C. Michael Gibson, Daniel I. Simon, Glenn N. Levine

October 30, 2016

Presentation TCT 2016

Acute Coronary Syndromes: NSTE-ACS

Presenter: Peter Barlis, Grzegorz L. Kaluza, Ziad A. Ali

October 29, 2016

Presentation TCT 2015

NSTE-ACS Case Presentation: From Presentation Through Discharge

Presenter: Ajay J. Kirtane, Gary S. Mintz, Manish A. Parikh, Bo Xu, Qi Zhang

October 11, 2015

Presentation TCT 2015

NSTE-ACS: Risk Stratification and Treatment

Presenter: Emmanouil S. Brilakis, Dmitriy N. Feldman

October 11, 2015

Advertisement

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

Case 2: Removing Ambiguity in NSTE-ACS Using Intravascular Imaging by OCT vs IVUS – Direct Comparison

Magnetic Endoscopy Capsule Reveals GI Damage Surprises From Antiplatelets

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

Acute Coronary Syndromes: Treatment of NSTE-ACS and STEMI

Statin Preloading Benefit More Pronounced in STEMI Patients: SECURE-PCI

Acute Coronary Syndromes: Treatment of NSTE-ACS and STEMI

Acute Coronary Syndromes: Treatment of NSTE-ACS and STEMI

Case Introduction: What Device(s) to Choose in a Patient With NSTE-ACS?

Case Conclusion: How Did We Treat Our Patient?

Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS

To Pretreat or Not to Pretreat? The DUBIUS Trial

Case Introduction: An Elderly Patient With NSTE-ACS

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Unmet Needs and Data Gaps for Pharmacotherapy in Patients With NSTE-ACS

Acute Coronary Syndromes: NSTE-ACS

NSTE-ACS Case Presentation: From Presentation Through Discharge

NSTE-ACS: Risk Stratification and Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content